Evaluation of the efficacy of use of fibrinogen in acquired coagulopathies

s / Thrombosis Research 129, Supplement 1 (2012) S155–S194 S177 Abstract PO-41 – Table 1. Catheter outcomes, by devicePO-41 – Table 1. Catheter outcomes, by device n=95 PICCs n=51 CVCs Number Percentage (%) Number Percentage (%) Male 48 50.5% 30 58.8% Female 47 49.40% 21 41.2% Median age Range 17–82 years 49.1 Range 23–78 years 50.5 Type of catheter Silicon rubber 6 6.3% CVC ST (short term) 35 68.63% Polyurethane 3 3.1% CVC LT (long term) 36 31.3% Polyurethane power injectable 86 90.5%